Lukong lab - new publication in Sci Adv
BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential
Xiang lab - new publication in Cell Mol Immunol
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
Vizeacoumar lab - new publication in Cancer Res
Banding Together: A Systematic Comparison of The Cancer Genome Atlas and the Mitelman Databases
Chelsea Cunningham was awarded a Health Sciences Graduate Scholarship
This graduate student scholarship will help support Chelsea during one year of her graduate program.
Dr. Anjuman Ara awarded a SHRF Postdoctoral Fellowship
Congratulations to Anjuman Ara (Xiang Lab), the recipient of a Saskatchewan Health Research Foundation Postdoctoral Fellowship, a two-year award. Anjuman’s project is titled: “Regulating T-cell fate by targeting mTORC1-KIF13A-M6PR axis to enhance immunity against cancer”.
New Publication from the Lukong Lab in Biomed Opt Express
Development of a low-cost and portable smart fluorometer for detecting breast cancer cells
Congratulations Trainee Presentation Winners at the Sixth Annual Saskatchewan Cancer Research Conference
The sixth annual Saskatchewan Cancer Research Conference was held June 11, 2019 in Saskatoon, with 110 registered participants from a wide range of disciplines in attendance. This conference recognizes and promotes the excellent cancer research within the province and provides valuable learning and networking opportunities for the participants.
Dr. Jim Xiang was awarded a 1-year Prostate Cancer Fight Foundation - TELUS Ride For Dad Grant
The title of this project is: “Eradication of localized prostate cancer by irreversible electroporation ablation”.
Dr. Jim Xiang was awarded a 5-year NSERC Discovery Grant
The title of this project is: “Simulated microgravity blocks osteoblastic differentiation and mineralization leading to bone loss via suppressing the FAK/RhoA-regulated Wnt pathway”.
Congratulations Riley Crittenden on being awarded a CIHR Scholarship
Riley (Anderson lab) received a Master's Award: Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). Her project is titled: " Identification of new drugs to treat triple negative breast cancer".
Dr. Deborah Anderson was awarded a University of Saskatchewan CIHR Bridge Funding Grant
The project supported by this grant is: "New therapies for triple negative breast cancer".
Dr. Anjuman Ara awarded a CoM Postdoctoral Fellowship
Congratulations to Anjuman Ara (Xiang Lab), the recipient of a College of Medicine Postdoctoral Fellowship, a two-year award. Anjuman’s project is titled: “Regulating T-cell fate by targeting mTORC1-KIF13A-M6PR axis to enhance immunity against cancer”.
New Review Article Published by the Vizeacoumar Lab in Prog Biophys Mol Biol
Targeting the CINful genome: Strategies to overcome tumor heterogeneity
Dr. Sharmila Narayanan awarded a Saskatchewan Cancer Agency Postdoctoral Fellowship
Congratulations to Sharmila Narayanan (Vizeacoumar Lab), the recipient of a Saskatchewan Cancer Agency Postdoctoral Fellowship, a two-year award. Sharmila’s project is titled: “Understanding the role of circular RNA in triple negative breast cancer”.
Dr Keith Bonham was awarded a Saskatchewan Cancer Agency grant
This 2-year grant is titled: ‘Preclinical evaluation of HDAC inhibitors in combination therapy.’
New Publication from the Vizeacoumar and Bonham Labs in Mol Oncol
Molecular characterization of an MLL1 fusion and its role in chromosomal instability
New Publication from the Lukong, Anderson and Vizeacoumar Labs in BMC Cancer
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
New Review Article Published by the Anderson Lab in Biomolecules
Impact of p85α Alterations in Cancer
New Review Article Published by the Vizeacoumar Lab in Trends Cancer
A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality